重组人β-Galactosidase(β半乳糖苷酶)-RNAi技术-试剂-生物在线
上海沪震实业有限公司
重组人β-Galactosidase(β半乳糖苷酶)

重组人β-Galactosidase(β半乳糖苷酶)

商家询价

产品名称: 重组人β-Galactosidase(β半乳糖苷酶)

英文名称: Recombinant Human beta-Galactosidase

产品编号: HZ1697

产品价格: 0

产品产地: 中国/上海

品牌商标: 沪震生物

更新时间: 2023-08-17T10:24:20

使用范围: null

上海沪震实业有限公司
  • 联系人 : 鲍丽雯
  • 地址 : 上海市闵行区闵北路88弄1-30号第22幢AQ136室
  • 邮编 : 200612
  • 所在区域 : 上海
  • 电话 : 139****0749 点击查看
  • 传真 : 点击查看
  • 邮箱 : www.shzbio.net
  • 二维码 : 点击查看

 重组人β-Galactosidase(β半乳糖苷酶)

中文名称:重组人β-Galactosidase(β半乳糖苷酶)
英文名称:Recombinant Human beta-Galactosidase
产品规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成,目的基因编码的Leu24-Val677在C端含有His标签。

β-Galactosidase质量控制:>95%(还原性SDS-PAGE)

β-Galactosidase制剂:液体

β-Galactosidase保存:收到货后请置于-20℃,可保存6个月,避免反复冻融。

关于β-Galactosidase
β Galactosidase is a lysosomal β Galactosidase that hydrolyzes the terminal β Galactose from Ganglioside and Keratan sulfate. In lysosome, the mature β Galactosidase protein associates with Cathepsin A and Neuraminidase 1 to form the lysosomal multienzyme complex . An alternative splicing at the RNA level of β Galactosidase results a catalytically inactive β Galactosidase that plays an important role in vascular development. Defects of β-galactosidase (GLB1) are the cause of diseases like GM1-gangliosidosis which is a lysosomal storage disease and Morquio Syndrome B that cause patients to have abnormal elastic fibers. More than 100 mutations have been identified for β Galactosidase, which result in different residual activities of the mutant enzymes and a spectrum of symptoms in the two related diseases. 

特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!